HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/2/C453    most recent 00068.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by van der Velden, J. L. J. Articles by Schols, A. M. W. J. Search for Related Content PubMed PubMed Citation Articles by van der Velden, J. L. J. Articles by Schols, A. M. W. J.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

Inhibition of glycogen synthase kinase-3 activity is sufficient to stimulate myogenic differentiation

¹Department of Respiratory Medicine, Maastricht University, Maastricht, The Netherlands; and ²Department of Pathology, University of Vermont, Burlington, Vermont

Submitted 16 February 2005 ; accepted in final form 8 September 2005

Skeletal muscle atrophy is a prominent and disabling feature of chronic wasting diseases. Prevention or reversal of muscle atrophy by administration of skeletal muscle growth (hypertrophy)-stimulating agents such as insulin-like growth factor I (IGF-I) could be an important therapeutic strategy in these diseases. To elucidate the IGF-I signal transduction responsible for muscle formation (myogenesis) during muscle growth and regeneration, we applied IGF-I to differentiating C₂C₁₂ myoblasts and evaluated the effects on phosphatidylinositol 3-kinase (PI3K)/Akt/glycogen synthase kinase-3 (GSK-3) signaling and myogenesis. IGF-I caused phosphorylation and inactivation of GSK-3 activity via signaling through the PI3K/Akt pathway. We assessed whether pharmacological inhibition of GSK-3 with lithium chloride (LiCl) was sufficient to stimulate myogenesis. Addition of IGF-I or LiCl stimulated myogenesis, evidenced by increased myotube formation, muscle creatine kinase (MCK) activity, and troponin I (TnI) promoter transactivation during differentiation. Moreover, mRNAs encoding MyoD, Myf-5, myogenin, TnI-slow, TnI-fast, MCK, and myoglobin were upregulated in myoblasts differentiated in the presence of IGF-I or LiCl. Importantly, blockade of GSK-3 inhibition abrogated IGF-I- but not LiCl-dependent stimulation of myogenic mRNA accumulation, suggesting that the promyogenic effects of IGF-I require GSK-3 inactivation and revealing an important negative regulatory role for GSK-3 in myogenesis. Therefore, this study identifies GSK-3 as a potential target for pharmacological stimulation of muscle growth.

insulin-like growth factor I; muscle hypertrophy

This article has been cited by other articles:

				M. M. Mariappan, M. Shetty, K. Sataranatarajan, G. G. Choudhury, and B. S. Kasinath Glycogen Synthase Kinase 3{beta} Is a Novel Regulator of High Glucose- and High Insulin-induced Extracellular Matrix Protein Synthesis in Renal Proximal Tubular Epithelial Cells J. Biol. Chem., November 7, 2008; 283(45): 30566 - 30575. [Abstract] [Full Text] [PDF]

				J. L. J. van der Velden, R. C. J. Langen, M. C. J. M. Kelders, J. Willems, E. F. M. Wouters, Y. M. W. Janssen-Heininger, and A. M. W. J. Schols Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1636 - C1644. [Abstract] [Full Text] [PDF]